NantHealth (NH) Tops Q4 EPS by 1c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results
March 28, 2019 4:15 PM EDTTotal Revenue in Q4 was $22.9 Million SaaS revenue of $17.3 million in Q4, up 9% from Q3 Enhanced efficiencies continued to drive significantly lower operating expenses in both Q4 and full year of 2018 For 2018, substantially improved adjusted Non-GAAP bottom line results Sequencing and Molecular Analysis, 1,021 total tests ordered in Q4, including 539 GPS Cancer® and 482 Liquid GPS Tests; continued sequential quarterly growth in total tests ordered
CULVER CITY, Calif.--(BUSINESS WIRE)-- NantHealth, Inc. (NASDAQ-GS:... More
